Abstract: A medical device includes a first housing portion (FHP) and a second housing portion (SHP) configured to be to be movable relative to each other from a first position to operatively engage at a second position to couple at least one of a drive device and a needle-inserting device supported by one of the FHP and the SHP to a reservoir supported by the other of the FHP and the SHP. Electronic circuitry configured to detect at least one of a first magnetic interaction between a magnet and at least one of a first magnetically attractive material and a first magnet-responsive device and a second magnetic interaction between the magnet and at least one of a second magnetically attractive material and a second magnet-responsive device, and to provide a signal or a change in state in response to detecting at least one of the interactions.

Abstract: A medical device control handle has a first actuation assembly and a second actuation assembly, wherein each assembly has a shaft that is axially aligned but not rotationally coupled with the other shaft. The first actuation assembly includes a first actuation member and a clutch mechanism having a friction disk for generating frictional torque in rendering the first actuation member self-holding. The first actuation member has a cam portion adapted to impart translational motion and rotational motion for disengaging the clutch mechanism upon pivotation of the first actuation member, thus allowing rotation of the first shaft to manipulate a feature of the medical device, for example, deflection. The second actuation assembly includes a second actuation member and a translating member that is responsive to rotation of the second shaft so as to manipulate another feature of the medical device. The second actuation member is also self holding.

Abstract: Various fluid delivery systems are described comprising an infusion pump having a housing with a first opening and a hollow interior portion that is configured to receive a cartridge having a tubing. A pump unit can be disposed within the housing. The pump unit comprises a motor mechanically coupled with a crank shaft or eccentric cam that is configured to move a set of pistons or other objects to thereby compress one or more portions of the tubing over time as the crank shaft or eccentric cam rotates.

Abstract: A safety needle has a needle base, a puncture needle, and a safety cap. The puncture needle is inserted into a front end of a needle connection segment of the needle base. The safety cap is combined with a front end of the needle base. The safety cap has a needle cap and a resilient member mounted in the needle base. The needle cap is mounted around the puncture needle. Guiding blocks formed on the rear end of the needle cap are mounted respectively in positioning recesses in a housing of the needle base. The needle cap and an outer cap are mounted around the puncture needle, and the puncture needle can be kept from exposure. The needle cap can be locked with the positioning recesses, and the safety needle cannot be reused and can be distinguished as a used needle.

Abstract: Medication delivery devices are provided having a dose delivery sensing capability. A sensed element is attached to a dose setting member of the device. The sensed element includes surface features radially-spaced from one another. A rotational sensor is attached to an actuator of the device. The rotational sensor includes a movable element that is contactable against the surface features. The rotational sensor is configured to generate a signal in response to the movement of the movable element over the surface features during their rotation. A controller is operatively coupled to the rotational sensor, and in response to receiving the generated signal, the controller is configured to determine a number of the surface features passing the movable element of the rotational sensor during dose delivery. The number can be associated with an amount of dose delivered. Sensing can be provided in a module or integrated in device.

Abstract: Devices, kits and methods for determining the site of intramuscular injection in adult and child patients are disclosed. The device includes a top element and two legs that are configured to be fastened in a first position and a second position. When placed in the first position and second position, the device forms a substantially triangular region having a center that corresponds to the site of injection.

Abstract: A syringe assembly is provided comprising a syringe cylinder extending from an opening configured to receive a plunger to an end configured to couple with a needle and/or medical tubing, a cap configured to couple to the end, and barrier material at least partially encompassing the cap and the end. A syringe assembly is provided comprising a syringe cylinder extending from an opening configured to receive a plunger to an end configured to couple with a needle and/or medical tubing, a plunger extending from one end to a seal end, and at least one cap configured to couple to the one end. A syringe assembly is provided comprising a syringe cylinder extending from an opening configured to receive a plunger to an end configured to couple with a needle and/or medical tubing, and a plunger extending from one end to a seal end, the one end of the plunger defining a recess configured to receive at least one cap.

Abstract: Described here are systems and methods for accessing Schlemm's canal and for delivering an ocular device or fluid composition therein. The ocular devices may maintain the patency of Schlemm's canal without substantially interfering with transmural fluid flow across the canal. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. Tools for disrupting these tissues and minimally invasive methods for treating medical conditions associated with elevated intraocular pressure, including glaucoma, are also described.

Abstract: An injection device having a delivery element with an inner thread may be driven by rotation and includes a cylindrical outer wall region, which is substantially smooth. Such features provide a delivery element configured such that it is less intimidating to patients than known threaded rods, and may facilitate easy cleaning. The delivery element may be non-rotatably guided and axially spring-loaded, and may be inserted axially into the housing when the reservoir is replaced. The driving thread element for the delivery element may be mounted in the vicinity of the distal end of the housing.

Abstract: A mechanical fluid pressure modification valve, or “MFLP-valve”, is set forth. The MFLP-valve can be actuated upon movement of a movable pressure system member of a medical pressure system reaching a selected position. Additionally, the MFLP-valve can be actuated based on a pressure condition of the system. When the MFLP-valve unseals, a pressure differential between a pressure chamber and a volume outside of the chamber can be relieved. Disengagement of the movable pressure system member from the MFLP-valve can enable the MFLP-valve to re-seal. The MFLP-valve may include a flag that indicates the position of the movable pressure system member. The MFLP-valve may be provided in a diaphragm-type pressure source.

Abstract: Inflation devices configured to communicate with remote displays are disclosed herein. Systems including such inflation devices with portable display devices are also disclosed herein. Methods of pairing a medical device to a portable display and remotely displaying pressure data from a medical device are also disclosed herein. Devices, systems, and methods of connecting medical devices to remote displays using proximity pairing and visual aids, and transferring information to or from linked computers are also disclosed.

Abstract: A lavage catheter for the treatment of a maxillary sinus is described. The catheter comprises a proximal portion and a distal portion. The distal portion comprises an irrigation tip. The irrigation tip has a tip opening through which fluid may be delivered by one handed operation of the catheter. A method for lavaging the maxillary sinus includes inserting the lavage catheter into a patient's anatomy and advancing the irrigation tip into the maxillary sinus using one hand.

Abstract: A drug administration device including a push button, plunger, housing extending in an axial direction to define top and bottom ends, and bolus refill indicator is provided. The indicator is disposed on the plunger and visible through a window in the housing. The indicator can include a first section having a first color located towards the top end of the housing, a second section having a second color located towards the bottom end of the housing, and a third section disposed therebetween including a gradient between the first and second colors. Alternatively, the indicator can include a line extending in a direction perpendicular to the axial direction. The housing includes a first indicator reference point that is a first color and aligned with a bottom of the indicator window and a second indicator reference point that is a second color and aligned with a top of the indicator window.

Abstract: A patch-sized fluid delivery device may include a reusable portion and a disposable portion. The disposable portion may include components that come into contact with the fluid, while the reusable portion may include only components that do not come into contact with the fluid. Redundant systems, such as redundant controllers, power sources, motor actuators, and alarms, may be provided. Alternatively or additionally, certain components can be multi-functional, such a microphones and loudspeakers that may be used for both acoustic volume sensing and for other functions and a coil that may be used as both an inductive coupler for a battery recharger and an antenna for a wireless transceiver. Various types of network interfaces may be provided in order to allow for remote control and monitoring of the device.

Abstract: Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device to deliver fluid to a user in accordance with an operating mode involves identifying a fluid type associated with the fluid currently onboard the infusion device from among a plurality of possible fluid types that is different from a previous type of fluid previously onboard the infusion device. The identified fluid type has pharmacokinetics characteristics that are different from pharmacokinetics characteristics associated with the previous fluid type. The method continues by updating one or more parameters referenced by a control module of the infusion device implementing the operating mode to reflect the pharmacokinetics characteristics associated with the identified fluid type and autonomously operating the infusion device to deliver the fluid of the identified fluid type to the user in accordance with the operating mode and the one or more updated control parameters.

Abstract: A tool (10) for inserting a catheter (22) into a body of a patient is provided. The tool (10) comprises: a housing (12, 40, 50) in which at least a portion of the catheter (22) is initially disposed; a needle (16) distally extending from the housing (12, 40, 50), at least a portion of the catheter (22) disposed over the needle (16); a guidewire (32) initially disposed within the needle (16) partially; and an advancement assembly (20) for distally advancing the catheter (22). The housing (12, 40, 50) comprises: a first portion (12A, 42, 52) comprising a distal part (42A, 52A) and a proximal part (42B); and a second portion (12B, 44, 54) engaged with the first portion (12A, 42, 52), wherein the distal part (42A, 52A) of the first portion (12A, 42, 52) is configured to be able to distally slide with respect to the second portion (12B, 44, 54) to release the engagement between the first portion (12A, 42, 52) and the second portion (12B, 44, 54).

Abstract: A connector comprises a body having a tubing portion and a luer portion axially opposite the tubing portion and connected thereto, an internal passageway defined by an inner circumferential surface of the connector, the passageway extending axially between the tubing portion and the luer portion and in fluid communication therewith, a stopping mechanism disposed in the luer portion and configured to limit an extent of a fluid line disposed in the connector, and a retaining mechanism disposed in the tubing portion and configured to retain the fluid line in the connector.

Abstract: A trans-anal irrigation (TAI) device has a pump base unit, an irrigation fluid reservoir, a wireless electronic controller, fluid tubing, and a disposable rectal catheter in fluid communication with the tubing. The rectal catheter has a retention balloon and a waste control valve. The fluid tubing contains two or three separate lumens for irrigation fluid and retention balloon inflation/deflation and optionally for waste control valve actuation. None of the lumens ever communicates with any other lumen. A hydraulic control circuit has a pump that pumps in one direction only but, with suitable control valves, is able to pump water to and from the retention balloon and to and from an optional waste control valve. A water temperature sensor is mounted in the pump base unit at a thin-wall section. The temperature sensor sends a signal to a controller which provides an indication of whether the water temperature is suitable for use.

Abstract: A catheter or shaft, such as a distal access support or aspiration catheter, is provided that is configured to be advanced at least partially within a patient. The catheter or shaft may include a flexible and hollow shaft including a proximal end and a distal end. The flexible and hollow shaft may include a slotted portion with a plurality of slotted openings, the slotted portion including a first segment with a first pattern of slotted openings and a second segment extending proximally relative the first segment with a second pattern of slotted openings different from the first pattern.

Abstract: Embodiments of the present invention are directed to the treatment of hypertension, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pains, asthma, pulmonary arterial hypertension, and chronic obstructive pulmonary disease by delivering of an effective amount of formulations at desired temperature to target tissue. The formulations include gases, vapors, liquids, solutions, emulsions and suspensions of one or more ingredients. The temperature may enhance safety and efficacy of the formulations for the treatments. The amounts of the formulation and/or energy are effective to injury or damage the tissues to have a benefit of symptom relive.